Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Martin, M; Chan, A; Dirix, L; O'Shaughnessy, J; Hegg, R; Manikhas, A; Shtivelband, M; Krivorotko, P; Lopez, NB; Campone, M; Borrego, MR; Khan, QJ; Beck, JT; Vazquez, MR; Urban, P; Goteti, S; Di Tomaso, E; Massacesi, C; Delaloge, S.

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2-advanced breast cancer (BELLE-4)

ANNALS OF ONCOLOGY. 2017; 28(2): 313-320 Nº de citas: 159 [doi:10.1093/annonc/mdw562]

Wapnir, IL; Gelber, S; Anderson, SJ; Mamounas, EP; Robidoux, A; Martin, M; Nortier, JWR; Geyer, CE; Paterson, AHG; Lang, I; Price, KN; Coates, AS; Gelber, RD; Rastogi, P; Regan, MM; Wolmark, N; Aebi, S.

Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial

ANNALS OF SURGICAL ONCOLOGY. 2017; 24(2): 398-406 Nº de citas: 25 [doi:10.1245/s10434-016-5571-y]

Sharma, P; Lopez-Tarruella, S; Garcia-Saenz, JA; Ward, C; Connor, CS; Gomez, HL; Prat, A; Moreno, F; Jerez-Gilarranz, Y; Barnadas, A; Picornell, AC; del Monte-Millan, M; Gonzalez-Rivera, M; Massarrah, T; Pelaez-Lorenzo, B; Palomero, MI; del Val, RG; Cortes, J; Rivera, HF; Morales, DB; Marquez-Rodas, I; Perou, CM; Wagner, JL; Mammen, JMV; McGinness, MK; Klemp, JR; Amin, AL; Fabian, CJ; Heldstab, J; Godwin, AK; Jensen, RA; Kimler, BF; Khan, QJ; Martin, M.

Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts

CLINICAL CANCER RESEARCH. 2017; 23(3): 649-657 Nº de citas: 113 [doi:10.1158/1078-0432.CCR-16-0162]

Echavarria, I; Granja, M; Bueno, C; Lopez-Tarruella, S; Peinado, P; Sotelo, M; Jerez, Y; Moreno, F; Torres, G; Lobo, M; Marquez-Rodas, I; Del Monte-Millan, M; Martin, M; Garcia-Saenz, JA.

Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer

BREAST CANCER RESEARCH AND TREATMENT. 2017; 162(1): 181-189 Nº de citas: 13 [doi:10.1007/s10549-016-4098-z]

D'Angelo, SP; Larkin, J; Sosman, JA; Lebbe, C; Brady, B; Neyns, B; Schmidt, H; Hassel, JC; Hodi, FS; Lorigan, P; Savage, KJ; Miller, WH; Mohr, P; Marquez-Rodas, I; Charles, J; Kaatz, M; Sznol, M; Weber, JS; Shoushtari, AN; Ruisi, M; Jiang, J; Wolchok, JD.

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

JOURNAL OF CLINICAL ONCOLOGY. 2017; 35(2): 226 Nº de citas: 475 [doi:10.1200/JCO.2016.67.9258]

Echavarria, I; Jerez, Y; Martin, M; Lopez-Tarruella, S.

Incorporating CDK4/6 Inhibitors in the Treatment of Advanced Luminal Breast Cancer

Breast Care. 2017; 12(5): 296-302 Nº de citas: 8 [doi:10.1159/000481656]

Echavarria, I; Lopez-Tarruella, S; Marquez-Rodas, I; Jerez, Y; Martin, M.

Neratinib for the treatment of HER2-positive early stage breast cancer

EXPERT REVIEW OF ANTICANCER THERAPY. 2017; 17(8): 669-679 Nº de citas: 19 [doi:10.1080/14737140.2017.1338954]

Escobar, IG; Rebollo, MA; Adrian, SG; Rodriguez-Garzotto, A; Martin, AM.

Safety and efficacy of primary thromboprophylaxis in cancer patients

CLINICAL & TRANSLATIONAL ONCOLOGY. 2017; 19(1): 1-11 Nº de citas: 5 [doi:10.1007/s12094-016-1500-6]

Marquez-Rodas, I; Lobo, M; Flores-Sanchez, C; Sanz, M; Luque, S; Lizarraga, S; Gonzalez-Asanza, C; Pajares, JA; Peligros, MI; Bueno, O; Mata, C; Lopez, C; Lopez-Tarruella, S; Jerez, Y; Munoz-Martin, A; Blanco, M; Die-Trill, M; Justel, JP; Solera, J; Martin, M.

Five Years of Multidisciplinary Care in Hereditary Cancer: Our Experience in a Spanish University Hospital

ONCOLOGY. 2017; 92(2): 68-74 Nº de citas: 3 [doi:10.1159/000452280]

Castello, A; Buijsse, B; Martin, M; Ruiz, A; Casas, AM; Baena-Canada, JM; Pastor-Barriuso, R; Antolin, S; Ramos, M; Munoz, M; Lluch, A; de Juan-Ferre, A; Jara, C; Lope, V; Jimeno, MA; Arriola-Arellano, E; Diaz, E; Guillem, V; Carrasco, E; Perez-Gomez, B; Vioque, J; Pollan, M.

Evaluating the Applicability of Data-Driven Dietary Patterns to Independent Samples with a Focus on Measurement Tools for Pattern Similarity

Journal of the Academy of Nutrition and Dietetics. 2016; 116(12): 1914 Nº de citas: 21 [doi:10.1016/j.jand.2016.05.008]

Gravalos, C; Rodriguez, C; Sabino, A; Segui, MA; Virizuela, JA; Carmona, A; Cassinello, J; Isla, D; Jara, C; Martin, M.

SEOM Clinical Guideline for bone metastases from solid tumours (2016)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2016; 18(12): 1243-1253 Nº de citas: 24 [doi:10.1007/s12094-016-1590-1]

de las Penas, R; Blasco, A; De Castro, J; Escobar, Y; Garcia-Campelo, R; Gurpide, A; Lopez-Lopez, R; Majem, M; Rodriguez, CA; Virizuela, JA.

SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2016; 18(12): 1237-1242 Nº de citas: 11 [doi:10.1007/s12094-016-1583-0]

Lopez-Pousa, A; Broto, JM; Trufero, JM; Sevilla, I; Valverde, C; Alvarez, R; Alvarez, JAC; Jurado, JC; Hindi, N; del Muro, XG.

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2016; 18(12): 1213-1220 Nº de citas: 27 [doi:10.1007/s12094-016-1574-1]

Garcia, KF; Ridruejo, JS; Olbes, PR; Molina, MSL; Arias, MIA.

Therapeutic attitude towards internal mammary chain drainage in patients with breast cancer

BREAST. 2016; 30: 1-4 Nº de citas: 6 [doi:10.1016/j.breast.2016.08.001]

Finn, RS; Martin, M; Rugo, HS; Jones, S; Im, SA; Gelmon, K; Harbeck, N; Lipatov, ON; Walshe, JM; Moulder, S; Gauthier, E; Lu, DRR; Randolph, S; Dieras, V; Slamon, DJ.

Palbociclib and Letrozole in Advanced Breast Cancer

NEW ENGLAND JOURNAL OF MEDICINE. 2016; 375(20): 1925-1936 Nº de citas: 2284 [doi:10.1056/NEJMoa1607303]

Garcia-Alfonso, P; Feliu, J; Garcia-Carbonero, R; Gravalos, C; Guillen-Ponce, C; Sastre, J; Garcia-Foncillas, J.

Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?

CLINICAL & TRANSLATIONAL ONCOLOGY. 2016; 18(11): 1072-1081 Nº de citas: 10 [doi:10.1007/s12094-016-1499-8]

Aviles-Izquierdo, JA; Molina-Lopez, I; Rodriguez-Lomba, E; Marquez-Rodas, I; Suarez-Fernandez, R; Lazaro-Ochaita, P.

Who detects melanoma? Impact of detection patterns on characteristics and prognosis of patients with melanoma

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2016; 75(5): 967-974 Nº de citas: 57 [doi:10.1016/j.jaad.2016.07.009]

Obermannova, R; Van Cutsem, E; Yoshino, T; Bodoky, G; Prausova, J; Garcia-Carbonero, R; Ciuleanu, T; Alfonso, PG; Portnoy, D; Cohn, A; Yamazaki, K; Clingan, P; Lonardi, S; Kim, TW; Yang, L; Nasroulah, F; Tabernero, J.

Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression(aEuro)

ANNALS OF ONCOLOGY. 2016; 27(11): 2082-2089 Nº de citas: 59 [doi:10.1093/annonc/mdw402]